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Abstract
Scutellaria barbata (S. barbata), a Chinese herb used in Traditional Chinese Medicine has
been known to contain anti-cancer properties. SB has been investigated as a potential treatment
for multiple types of cancer including colon cancer, glioblastoma, and ovarian cancer. Breast
cancer cell lines MDA-MB-157 and its APC-mutants 93A and 93B are more resistant to
treatment due to genetic modifications. In this study, the effectiveness of S. barbata in apoptotic
modulation of breast cancer cell lines MDA-MB-157, 93A, and 93B was investigated.
Assessments were performed using green/red/blue fluorescent Apoptosis/Necrosis Detection Kit
and the Human Apoptosis Antibody Array - Membrane (43 Targets) test by the Abcam
corporation. Our data demonstrated that 1-hour and 3-hour treatments with 2 mg aqueous extract
of S. barbata induced a statistically significant percentage of apoptosis in all cell lines.
Additionally, modulation of various apoptotic markers such as pro-apoptotic proteins Bad, Bax,
BIM, IGFBP-4, p53 and p27 was observed.
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Introduction
Cancer is one of the leading causes of deaths each year. Breast cancer is the second most
common cancer in American women, and the second leading cause of cancer death (American
Cancer Society, 2021). Statistics show that 1 in about 8 women in the United States will develop
invasive breast cancer in her lifetime (Breastcancer.org, 2021). Even though many cancer
treatments are now available, most of them are invasive, affecting the quality of life of those
suffering from the disease. Known treatments for cancer such as radiation therapy and
chemotherapy may cause severe side effects and drug resistance (Dai et al., 2013). In addition,
patients may also accumulate toxins and suffer from compromised immune systems after the
treatments.
Breast cancer was the most common type of cancer in the United States in 2019. There
were about 271,270 cases and 41,760 deaths that year, as published by the American Cancer
Society. By the end of 2021, there is a projected estimate of 281,550 new cases and 43,600
deaths. These elevated numbers clearly show that there is a need for new methods of research.
Therefore, it is worthwhile to investigate novel anti-cancer compounds.
Traditional Chinese Medicine, which focuses on the use of herbs for disease treatment
has been widely used in Asia for over two thousand years. It focuses on the use of herbs for
many medical problems, including stroke, heart disease, mental disorders, and respiratory
diseases. Nonetheless only in the last few decades have those herbs been studied by Western
medicine for their anti-cancer properties (Ye L., et al., 2015). As a result of the increased
interest in research, multiple herbs have been found to possess biologically active compounds
known as phytochemicals, which have anti-cancer characteristics (Dai et al., 2013). There are
two main molecular bases through which these phytochemicals are known to act against cancer:
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triggering apoptosis of cancer cells (guided multi-step pathway that ultimately causes cell death)
and by inhibiting angiogenesis (formation of new blood vessels within tumors) (Parekh, Liu, &
Wei, 2009). Thus, there is interest in developing less invasive remedies obtained from Chinese
herbs, which are usually administered by teas and are known to have less toxicity than current
drugs and cancer treatments (Perez et al., 2010).
Scutellaria barbata (S. barbata), is one of the herbs used in Traditional Chinese
Medicine for removal of toxic materials, improving circulation, removing blood stasis, and
reducing edema in the body. More recently, research has provided evidence for anti-cancer and
anti-inflammation properties (Chen, Rahman, Wang, Zhou, & Zhang, 2020). As a result, S.
barbata has been investigated as a potential treatment for multiple types of cancer including
colon cancer, lung cancer, ovarian cancer and breast cancer (Dai et al., 2013). Typically, these
studies use aqueous extracts from S. barbata followed by screening for anti-cancer properties
against multiple cell lines. Extracts from S. barbata induced apoptosis in proliferating ovarian
cancer cell lines in vitro (Powell et al., 2003) and effectively inhibited growth rate of hepatoma
in mice (Li et al., 2019). A study comparing the effectiveness of extracts of twelve different
Chinese herbs against human cancer cell lines, found that S. barbata showed specificity towards
growth inhibition of breast cancer cells. In addition, extracts of S. barbata have demonstrated
both antiproliferative activity as well as anti-cancer effects against lung, pancreas and prostate
cancer (Shoemaker M., et al, 2005). On prior years, Dr. Wong’s lab studied cell survival in
TRAMP mice finding that S. barbata modulated apoptosis on both murine and human prostate
cancer cells (Wong, B. Y., et. al, 2009).
Breast cancer cell lines MDA-MB-157 and its APC-mutants (93A and 93B) have been
genetically modified by the Harper Cancer Research Institute in collaboration with Indiana
University School of Medicine so that they can be resistant to treatment due to inhibition of the
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APC tumor suppressor gene. Normal function of the APC protein is to keep cells from growing
and dividing too fast or in an uncontrolled way (VanKlompenberg, M. K., et al, 2004).
In an effort to comprehend the anti-cancer properties of S. barbata, This study uses said
cell lines in order to investigate and understand the apoptotic effect that the aqueous extract has.
Two experimental procedures were performed. The first one was the Apoptosis and Necrosis
Detection Kit via fluorescent microscopy. The purpose of this procedure was to stain the cancer
cells with three different fluorescent markers, which provided differentiation between apoptotic,
necrotic and live cell. Apopxin green dye binds to cancer cells displaying the lipid molecule
Phosphatidylserine (a known apoptotic marker presents on the outside of the cell membrane),
which causes green fluoresce and indicate apoptosis. 7-ADD binds to the nucleus of cells that
have undergone necrosis (late stage of apoptosis) and do not have membrane integrity, causing
red fluoresce. Finally, CytoCalcein violet 450 binds to the cytoplasm of live and normal cancer
cells causing blue fluoresce. Blue cells indicate treatment ineffectiveness. Each cell line was
divided into a negative control group (distilled water added), positive control group
(Staurosporine added) and treatment group (S. barbata extract added). Once protocol was
completed, the results were analyzed through fluorescent microscopy. This methodology allowed
for the analysis of the effectiveness of the S. barbata extract in comparison to a known apoptotic
agent.
The second experimental procedure was the Human Apoptosis Antibody Array – (43)
Membrane detection. Some of the regulatory functions in apoptosis are ascribed to internal
signals from the Bcl-2 family of proteins which include Bad, Bax, Bid, Bim, among others.
These proteins interact with each other activating the downstream pathway of apoptosis. Some of
the proteins are characterized as anti-apoptotic (inhibiting apoptosis), while others are proapoptotic (promoting cell death) (Table 1). By using the 43 Apoptotic Marker Membrane Array,
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which contains specific antibodies for said proteins, quantification for levels of protein
expression was possible. The signal intensity for each antigen-specific antibody is proportional
to the concentration of protein in that sample. As a result, comparison of signal intensities seen
as darkness and size differences in the membranes can be quantified by taking X-ray images,
digitalizing them and using ImageJ to measure signal absorbances. Said procedure allowed for
values to be compared among positive, negative and control group for each cell line in order to
determine significant differences in anti-apoptotic and pro-apoptotic protein expression.
Therefore, determining the apoptotic modulation effect of S. barbata on cell lines MDA-MB
157, 93A and 93B.
The findings from this research will aid in the understanding of apoptosis on resistant
breast cancer cell lines MDA-MB 157, 93A and 93B for which not much information has been
collected. In addition, the modulation of various pro-apoptotic and anti-apoptotic proteins by S.
barbata will be studied, providing an insight on how the phytochemicals in the herb act in
promoting the action of specific apoptotic proteins.
Table 1. Function and description of the 43 proteins found in Human Apoptosis Antibody Array
membrane.
Protein
Bcl-2

Function
anti-apoptotic

Bcl-w

anti-apoptotic

cIAP-2

anti-apoptotic

Fas

anti-apoptotic

FasL

anti-apoptotic

HSP27

anti-apoptotic

HSP60

anti-apoptotic

Description
BCL2 (and its antiapoptotic orthologues, BCL-XL and BCL-W) seems to inhibit apoptosis by the
preservation of mitochondrial mem- brane integrity as its hydrophobic carboxyl-terminal domain is
linked to the outer membrane. BCL2 prevents BAX/BAK oligomerization, which would otherwise
lead to the release of several apoptogenic molecules from the mitochondrion. (Tzifi et al., 2012)
BCL2 (and its antiapoptotic orthologues, BCL-XL and BCL-W) seems to inhibit apoptosis by the
preservation of mitochondrial mem- brane integrity as its hydrophobic carboxyl-terminal domain is
linked to the outer membrane. BCL2 prevents BAX/BAK oligomerization, which would otherwise
lead to the release of several apoptogenic molecules from the mitochondrion. (Tzifi et al., 2012)
cIAP2 has been demonstrated to inhibit cell death by directly repressing the proapoptotic activity of
a family of cysteine proteases (25), caspases, as well as targeting proapoptotic components of the
TNF-α signaling pathway for ubiquitin degradation
(Tzifi et al., 2012)
FASL-FAS signaling triggers apoptosis through FADD (Fas-associated protein with death domain,
also called MORT1) adaptor protein-mediated recruitment and activation of the aspartate-specific
cysteine protease, caspase-8.
(Strasser, Jost, & Nagata, 2009)
FASL-FAS signaling triggers apoptosis through FADD (Fas-associated protein with death domain,
also called MORT1) adaptor protein-mediated recruitment and activation of the aspartate-specific
cysteine protease, caspase-8. (Strasser et al., 2009)
The role of Hsp27 in apoptosis is inhibition of apoptosome formation.
(Takayama, Reed, & Homma, 2003)
Hsp60 is a heat-shock protein that primarily localizes to the matrix of the mitochondria. Reduction
in HSP60 expression precipitates apoptosis
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HSP70

anti-apoptotic

IGF-I

anti-apoptotic

IGF-II

anti-apoptotic

IGFBP-1

anti-apoptotic

IGFBP-2

anti-apoptotic

IGF-1sR

anti-apoptotic

Livin

anti-apoptotic

p21
Survivin

anti-apoptotic
anti-apoptotic

TRAILR-3
TRAILR-4
XIAP

anti-apoptotic
anti-apoptotic
anti-apoptotic

Bad

pro-apoptotic

Bax

pro-apoptotic

BID

pro-apoptotic

BIM

pro-apoptotic

Caspase3

pro-apoptotic

Caspase 8
CD40

pro-apoptotic
pro-apoptotic

CD40L

pro-apoptotic

cytoC

pro-apoptotic

DR6

pro-apoptotic

HTRA

pro-apoptotic

IGFBP-3

pro-apoptotic

IGFBP-4

pro-apoptotic

IGFBP-5

pro-apoptotic

(Takayama et al., 2003)
Hsp70 directly binds to apoptosis-inducing factor (AIF), inhibiting AIF-dependent apoptosis.
(Takayama et al., 2003)
The main focal point of IGF-I is the regulation of Bcl-2 family proteins acting as an inhibitor of
apoptosis in many different cell types. (Kooijman, 2006)
This protein plays an essential role in growth and development before birth. Studies suggest that
insulin-like growth factor 2 promotes the growth and division (proliferation) of cells in many
different tissues.
https://medlineplus.gov/genetics/gene/igf2/
IGFBP1 protein localizes to mitochondria where it binds to the proapoptotic protein BAK and
hinders BAK activation and apoptosis induction.
(Leu & George, 2007)
GFBP-2 regulates caspase-3 expression and contributes to the inhibitory effect on apoptosis
independent of IGF. (Migita et al., 2010)
Insulin and IGF-1 binding stimulate receptor tyrosine kinase activity and blocks apoptosis. (Boucher
et al., 2010)
Livin is a member of the inhibitors of apoptosis (IAP) family, which plays crucial roles in apoptosis,
cell proliferation, and cell cycle control.
(Yan, 2011)
p21 induction primarily inhibits apoptosis by causing cell cycle arrest and DNA repair. (Abcam)
Survivin, a member of the inhibitor of apoptosis (IAP) protein family that inhibits caspases and
blocks cell death (Jaiswal, Goel, & Mittal, 2015)
Inhibits apoptosis; however not much about its mechanism is known
Inhibits apoptosis; however not much about its mechanism is known
X-chromosome-linked inhibitor of apoptosis protein (XIAP) inhibits caspases and blocks apoptosis
((Chaudhary et al., 2016)
BAD is released upon dephosphorylation [34]. BAD molecule is also cleaved by caspases when
apoptosis is induced by transforming growth factor β1. (Tzifi et al., 2012)
BAX protein is a monomeric protein in the cytosol, which integrates into the mitochondria during
apoptosis and subsequently oligomerizes, resulting to the release of apoptogenic factors like
cytochrome c and the activation of the caspase cascade. (Tzifi et al., 2012)
BID is activated by caspase-8 cleavage and N-myristoylation to target mitochondria, where it
activates BAX and BAK or is alternatively sequestered by antiapoptotic BCL2 members, preventing
death. (Tzifi et al., 2012)
BIM is a peptide found to induce cytochrome c release from mitochondria in vitro. It is thought to
trigger apoptosis by binding and therefore inactivating the antiapoptotic BCL2 relatives. (Tzifi et
al., 2012)
Caspase-3 is known as an executioner caspase in apoptosis because of its role in coordinating the
destruction of cellular structures such as DNA fragmentation or degradation of cytoskeletal proteins.
(Caspase, 3)
Plays a central role in the execution-phase of cell apoptosis.
CD40 ligation leads to TRAF recruitment and activation of the NF-κB and AP-1 pathways.
Activation of these transcription factors can promote proliferation or apoptosis in a signal and cell
type specific manner.
(Georgopoulos et al., 2006)
CD40 ligation leads to TRAF recruitment and activation of the NF-κB and AP-1 pathways.
Activation of these transcription factors can promote proliferation or apoptosis in a signal- and cell
type-specific manner.
(Georgopoulos et al., 2006)
Mitochondrial cytochrome c (cyt c) has been found to have dual functions in controlling both
cellular energetic metabolism and apoptosis. Through interaction with apoptoticprotease activating
factors (Apaf), cyt c can initiate the activation cascade of caspases once it is released into the
cytosol.
(Cai, Yang, & Jones, 1998)
DR6 was identified as a member of the TNF receptor-related death receptor family… and it was
found that DR6 induces apoptosis when it is overexpressed
(Zeng et al., 2012)
The HtrA family proteins are serine proteases that are involved in important physiological
processes, including maintenance of mitochondrial homeostasis, apoptosis and cell signaling.
(Zurawa-Janicka, Skorko-Glonek, & Lipinska, 2010)
Insulin-like growth factor binding protein-3 (IGFBP-3) has a role as a primary growth inhibitor, it
has been shown to increase ceramide-induced apoptosis and to enhance both p53-dependent and
p53-independent apoptosis
(Williams et al., 2007)
One of the IGF binding proteins called IGFBP-4 is well known for its growth inhibitory effect on
several cancer cells in vitro. overexpression of IGFBP-4 on established subcutaneous cancer model
can increase tumor apoptosis
(Durai, Yang, Seifalian, Goldspink, & Winslet, 2007)
Insulin-like growth factor binding protein-5 (IGFBP5) is important for cell growth control and the
induction of apoptosis. Silencing IGFBP5 with small interfering RNA significantly reduced
apoptosis and suppressed the expression of caspase-3 in NRVMs.
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IGFBP-6

pro-apoptotic

p27

pro-apoptotic

p53
SMAC

pro-apoptotic
pro-apoptotic

sTNF-R1

pro-apoptotic

sTNR-R2
TNF-a

pro-apoptotic
(selective)
pro-apoptotic

TNF-B

pro-apoptotic

TRAILR-1

pro-apoptotic

TRAILR-2

pro-apoptotic

(Leung et al., 2014)
IGFBP-6 has recently been shown to have a number of IGF-independent actions, including
promotion of apoptosis in some cells and inhibition of angiogenesis
(Bach, 2015)
p27 inhibits cyclin-CDK complexes from phosphorylating histone H1. Furthermore, overexpression
of p27 was found to prevent CDK activation and entry into the S phase of the cell cycle. (Abukhdeir
& Park, 2008)
P53 can activate BAX, which lacks a clearly identifiable BH3 domain. (Tzifi et al., 2012)
Smac/DIABLO is a mitochondrial protein that potentiates some forms of apoptosis, possibly by
neutralizing one or more members of the IAP family of apoptosis inhibitory proteins. Smac has
been shown to exit mitochondria and enter the cytosol during apoptosis triggered by UV- or γirradiation.
(Adrain, Creagh, & Martin, 2001)
TNF-alpha receptors. sTNFR1 exerts immunoregulatory functions by induction of apoptosis in
monocytes through reverse signaling via transmembrane TNF-alpha. (Waetzig et al., 2005)
TNF-alpha receptors. sTNFR2 exerts immunoregulatory functions by induction of apoptosis in
monocytes through reverse signaling via transmembrane TNF-alpha. (Waetzig et al., 2005)
TNF's main function is to stimulate inflammation by turning on gene transcription through the
IKK/NFκB and JNK/AP-1 signaling cascades. TNF also can trigger apoptosis through caspase-8
(Varfolomeev & Ashkenazi, 2004)
TNF's main function is to stimulate inflammation by turning on gene transcription through the
IKK/NFκB and JNK/AP-1 signaling cascades. TNF also can trigger apoptosis through caspase-8
(Varfolomeev & Ashkenazi, 2004)
TNF-related apoptosis-inducing ligand (TRAIL), is a protein functioning as a ligand that induces
the process of cell death called apoptosis.
TNF-related apoptosis-inducing ligand (TRAIL), is a protein functioning as a ligand that induces
the process of cell death called apoptosis.

Methods
General cells preparation protocols used for both experimental procedures
Making Cell Media (500ml)
-

Work in hood and wipe all bottles with alcohol

-

Warm stock RPIM media, FBS and Pen/Strep in water bath

-

Obtain empty/clean bottles: 250ml and 50ml

-

Remove 50ml of stock RPIM and place into clean 50ml bottle

-

Add 50ml of FBS and 5ml of Pen/Strep to 500ml EMEM stock bottle

-

Gently mix/swirl bottle

-

Remove 250ml of media from stock EMEM bottle and place into clean 250ml bottle

-

Label and date all media

Waste disposal: do NOT throw any antibiotics (Pen/Strep down the sink)
Herbal extraction protocol (S. Barbata)
-

Weigh graduated flask
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-

Weigh 10g herb and place in graduated flask

-

Add 100ml of sterile H2O

-

Incubate at 56C for 1 hr

-

Filter with Kim wipe to remove debris

-

Centrifuge at 3000rpm (upstairs)

-

Take supernatant and filter through buchner funnel with filter paper into 500ml
Erlenmeyer flask

-

Dry with rotovap, take dry weight and dissolve in H20 to appropriate concentration

-

Filter with sterile micro filter

Thawing Cells
-

Place vial of cells in a beaker with water and place the beaker in a 37°C water bath.

-

When the cells are thawed, titrate with 3mL syringe.

-

Add the cells to a 60mm cell culture dish that has 5mL warm media (if cold, place media

-

in hot water bath at the same time as cells to warm)

-

Change the media after 24 hours. Make sure to use 5mL media. Observe cells in dish
before and after changing media. Incubate.

Changing Media
-

Place media in 37°C water bath 15 minutes before use.

-

Make sure to disinfect hood, media bottle, and pipets before use.

-

With a new pipet, collect the old media in cell dish and throw in waste container.

-

Take a new pipet and obtain 5mL new media and add to cells. Observe and incubate
cells.

Passage of Cell Monolayers
-

Place media and trypsin in 37°C water bath to warm before use. When warm, spray and
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-

wipe bottles with ethanol and dry before placing under hood.

-

Remove the media from cells with a sterile pipet.

-

Rinse the cells with 1mL phosphate buffer and remove quickly.

-

Use a new, sterile pipet to put 3mL fresh trypsin onto the cells.

-

Incubate cells for 5 minutes.

-

After incubation, titrate with a new pipet to break apart clumps.

-

After titrating, add twice as much new media as the trypsin (6mL).

Part I: Apoptosis and Necrosis Detection Kit
Modified from the Abcam protocol ab176749. The purpose of this procedure is to stain the
cancer cells with three different fluorescent markers, which will provide differentiation between
apoptotic, necrotic and live cells based on the color. For each cell line there will be a negative
control (no treatment added), positive control (Staurosporine, a known potent agent that induces
apoptosis added) and a treatment group (S. barbata extract added).
Cell culture preparation:
-

Make cell media

-

Prepare aqueous herb extract through herbal extraction protocol

-

Thaw cells

-

Change media as often as needed

-

Passage of cell monolayers when enough cells have developed

Divide Cells into Plates
-

Place media, phosphate buffer, and trypsin bottles in 37°C water bath 15 minutes

-

before use.

-

Remove media from cells with pipet and place in waste bucket.
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-

With a new pipet, add 1mL phosphate buffer to cells and rinse. Remove with pipet and

-

put in waste.

-

Add 1mL trypsin to cells and swirl plate.

-

Check for detaching under microscope.

-

Incubate 5 minutes.

-

Check for detachment.

-

Add 2mL media (twice amount of trypsin) to cells.

-

Titrate cells vigorously 7-8 times, avoiding air bubbles.

-

Split the cells into 3 different plates and label plates 1, 2, 3.

-

Add 6mL media onto each plate.

Cell treatment and incubation:
-

Seed 5000 cells per well (200 μl). 12 wells per cell line.
o 6 wells for 3-hour treatment and 6 wells for 1-hour treatment.
o Within the 6 wells, 2 will be negative control, 2 will be positive control and 2 will
be experimental group (figure 1).

-

Incubate well plate overnight at 37˚C.

-

Remove reagents for apoptosis from refrigerator. Warm them up to room temperature.

-

Change cell media for each cell line and start treatment for 3-hour treatment.

-

Add 10 μl of staurosporine to positive control group.

-

Add 10 μl of DI water to negative control group.

-

Add 5 μl of S. barbata extract to treatment group.

-

Incubate well plate for 2 hours at 37˚C.

-

Repeat steps 5-7 to start 1-hour treatment.

-

Incubate well plate for 1 hour at 37˚C.
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-

Drain cell media from wells.

-

Wash wells with 100 μl of assay buffer.

-

Turn off lights and add fluorescent markers.
o Add 200 μl of assay buffer
o Add 2 μl of Apopxin green
o Add 1 μl of red 7-ADD
o Add 1 μl of blue CytoCalcein violet 450

-

Wrap in tin foil and incubate in Styrofoam box for 60 minutes.

-

Wash wells two times with 100 μl assay buffer. Plate is ready for observation.

-

Use fluorescent microscope to take pictures of each well in the plate (figure 2).

Data collection
-

For each cell line, a minimal number of 200 cells were counted per plate (experimental,
positive and negative). Depending on their color, each cell was categorized as normal
(blue), apoptotic (green), or necrotic (red).

-

Then, the means obtained were compared between the negative and treatment group
using a paired t-test. Said analysis provided the evidence to know whether there was a
significant increase of apoptotic cells on the treatment group (S. barbata added) in
comparison to the negative control group.

Part II: Human Apoptosis Antibody Array – (43) Membrane Protocol:
Some of the regulatory functions in apoptosis are ascribed to internal signals from the
Bcl-2 family of proteins. These proteins interact with each other activating the downstream
pathway of apoptosis. By using the 43 Apoptotic Marker Membrane Array we are able to
quantify levels of protein expression. The signal intensity for each antigen-specific antibody will
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be proportional to the concentration of the antigen in that sample. As a result, comparison of
signal intensities for individual antigen-specific antibody spots between and among array images
will allow for measurement of the apoptotic affect that S. barbata has on each breast cancer cell
line.
Cell culture preparation:
-

Make cell media

-

Prepare aqueous herb extract through herbal extraction protocol

-

Thaw cells

-

Change media as often as needed

-

Passage of cell monolayers when enough cells have developed

Divide Cells into Plates
-

Place media, phosphate buffer, and trypsin bottles in 37°C water bath 15 minutes

-

before use.

-

Remove media from cells with pipet and place in waste bucket.

-

With a new pipet, add 1mL phosphate buffer to cells and rinse. Remove with pipet and

-

put in waste.

-

Add 1mL trypsin to cells and swirl plate. Check for detaching under microscope.
Incubate 5 minutes.

-

Check for detachment.

-

Add 2mL media (twice amount of trypsin) to cells.

-

Titrate cells vigorously 7-8 times, avoiding air bubbles.

-

Split the cells into 3 different plates and label plates 1, 2, 3.

-

Add 6mL media onto each plate.
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Cell Treatment
-

Change media on the plates, adding 5mL new media onto each plate.

-

Add 200 μL SB to plate 1, 200 μL DI water to plate 2, and 200 μL apoptotic agent to
plate 3.

-

Incubate plates for 3 hours.

Cell lysate preparation
-

Wash cells 2 times with cold 1X PBS buffer.

-

Spin cells down for 10 minutes at 1500 rpm.

-

Remove remaining liquid from cell pellet.

-

Add 1X lysis buffer to cell pellet. Pipette cells up and down to resuspend cells.

-

Incubate at 4˚C for 30 minutes, with gentle rocking or shaking.

-

Spin down lysates at 14000 x g for 10 minutes.

-

Transfer supernatant to fresh microfuge tubes. 500 μl per tube.

Protein Assay Dye
-

Make BSA 100ng/µL working protein solution: take 14.4µL of BSA and add 985.6µL of
DDH2O =100ng/µL.

-

Determine standard curve by placing the correct amounts of H2O, Dye & BSA into each
cuvette. (Table 1).

-

Determination of protein concentration of the extracted lysate of your samples:
o

Obtain 3 cuvettes for the lysate samples and label A, B, C.

o Into each of the three cuvettes place 790µL H2O, 200µL protein assay dye, and
10µL lysate (your extracted protein solution). Leave for 5 minutes.
o
-

mix/gently titrate before measuring absorbance.

Measure absorbance at A595
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o First measure cuvette 1 from standard curve as reference.
o Measure remaining standard curve cuvettes and record absorbance.
o Measure the three lysate sample cuvettes and record absorbance.
o Plot data for standard curve: absorbance vs. concentration.
-

Membrane:
o Repeat Process for each of the three cell lines samples.
o Use equation given from standard curve (y=mx+b) and substitute y with the
absorbance from the lysate sample in order to find protein concentration.
o Solve for protein x (ng/µL) and convert to µg/µL.

Blocking and Incubations
-

Place each membrane printed side up into the 8-well tray provided in the kit.

-

Add 2 mL 1X Blocking Buffer to each membrane. Incubate at room temp for 30 min
with gentle rocking or shaking to block the membrane surface.

-

Decant Blocking Buffer and add fresh 1.2mL of Blocking Buffer. Add X µL of sample
(Blocking Buffer + X µL of sample calculated from Protein Assay). Incubate membranes
overnight at 4˚ Celsius with gentle rocking or shaking. (Place the lid on the 8 well tray
during overnight incubation).

-

Aspirate samples from membranes and wash 3x for 5 min with 2 mL Wash Buffer I at
RT, use fresh buffer for each wash.
o Large Volume Wash to reduce background.

-

Add 20-30 mL of Wash Buffer I per membrane and wash at RT with gentle shaking or
rocking for 30-45 min. Return membranes to the 8 well tray.

-

Wash 2x 5 min with 2 mL of 1X Wash Buffer II each at RT. Decant and use fresh wash
buffer each time.
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-

Add 1 mL of 1X Biotin-conjugated Anti-Cytokines to each membrane. Incubate
overnight at 4˚ Celsius with gentle rocking or shaking (Place the lid on the 8-well tray for
overnight incubation to prevent evaporation).

-

Aspirate (remove) Anti-Cytokine reagent with pipette. Repeat washes in step 4 and 5.

-

Add 1.5 mL of 1X Streptavidin-HRP and incubate at room temperature for 2 hours.

-

Repeat washes in step 4 and 5.

-

Proceed with Chemiluminescent Detection protocol below or store membrane for
detection at a later date.

Chemiluminescence Detection
-

Place a plastic sheet (provided in the kit) on your benchtop.

-

Place one or more array membranes protein side up on the plastic sheet. Drain excess
liquid by touching one edge to blotting paper on tissue paper.

-

Into a single, clean tube, add equal volumes of Detection Buffer C and Detection Buffer
D immediately prior to detection. Mix well. Add 250 μl of each buffer per membrane to
be detected.
o For 9 membranes, combine 1 ml of each detection buffer.

-

Pipette the mixed Detection Buffers on to each membrane. Place another plastic sheet on
top, gently smooth out any air bubbles. Incubate at room temperature for 2 minutes.

-

Remove top plastic sheet and remove excess liquid.

-

Gently replace the membranes (protein side up) on the bottom plastic sheet and replace
the top plastic sheet with wrap. Gently smooth out any air bubbles on the membrane
surfaces.

-

Detect signals exposing the array membranes to X-ray film and detect the signal using a
film developer.
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o Transfer the membrane, protein side down, to the plastic wrap. Fold the plastic
wrap over well to completely cover the membrane.
o Place a pre-cut piece of x-ray film over the membrane. Cut the top right corner of
the film for orientation in the cassette.
o Close the cassette an expose between 5 to 20 seconds. The signal rapidly
decreases over time.
o Remove x-ray film, dip in the developer until you see bands.
o Wash by dipping in water container several times.
o Place in the fixer for 3 min.
o Wash by dipping in water container several times.
o Hang by hook on wire until dry.
-

X-ray is ready for observation (Figure 1).

Figure 1. Human Apoptosis Antibody Array X-ray film for Breast cancer cell line MDA-MB157
Obtaining densitometry data
-

Scan X-ray film to obtain digitized image using an off-ice scanner with resolution of
300dpi or greater.

-

Use densitometry software ImageJ to obtain spot signal densities from scanned images
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-

For each membrane identify single exposure that exhibit low background signal intensity
and strong positive control signals that do not “bleed” into each other.

-

Measure the density of each spot using the Protein Array Analyzer plugin macro.
o Obtain colored spot signal densities (Figure 2).

-

Once the raw densitometry data has been collected repeat procedure for each cell line
membrane.

Figure 2. Human Apoptosis Antibody Array X-ray film with respective ImageJ software protein
array analyzer results for Breast Cancer cell lines MDA-MB 157.
Results
Part I: Apoptosis and Necrosis Detection Kit
Fluorescent apoptosis results (Figure 3) reveal that aqueous extract of SB induced a
statistically significant percentage of apoptosis during 1-hour incubation in MDA-MB-157 (46.5
± 7.5% > 16%± 1.0%, p < 0.05); 93A (54.5 ± 2.5% > 0%, p < 0.05); and 93 B (65.5 ± 13.5% >
0%, p < 0.05).
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Similar results were obtained with 3-hour incubation. MDA-MB-157 (65.5 ± 1.5% >
28%± 1.0%, p < 0.05); 93A (71 ± 8% > 17 ±15%, p < 0.05); 93B (89 ± 1% > 16 ± 3%, p < 0.05).

Figure 3. Fluorescent microscopy pictures demonstrating 1-hour and 3-hour incubation results
after treatment with 2mg of aqueous SB extract for cell lines (A) MDA-MB 157, (B) 93A and
(C) 93B. Blue fluorescence indicates cytoplasm staining (normal live-cells), green fluorescence
indicates inner phosphatidylserine exposure (apoptosis) and red fluorescence of the nucleus
indicates loss of cell membrane (necrosis).

Part II: Human Apoptosis Antibody Array – (43) Membrane Protocol
Antibody Array Membrane ImageJ results for all cell lines (Figure 4) demonstrates that there
was a statistically significant difference (p<0.05) between groups in the expression of the
following pro-apoptotic proteins after analysis by one-way ANOVA (Table 2, 3, 4) and Tukey
post hoc test:
•

MDA-MB-157: BID (p=0.019) and BIM (p=0.007), IGFBP-4 (0.017), TNF-a (0.031)

•

93A: Bad (p=0.02), BIM (p=0.001), C3(p=0.015), cytoC (0.030), IGFBP-3 (0.049),
IGFBP-4 (0.014), IGFBP-6 (0.004), p53 (p=0.004) and sTNF-R2 (0.032).

•

93B: All proteins except IGFBP-6 had p<0.05. Some of the most important values are
Bad (p=0.002), Bax (p=0.020), BID (p=0.001), p27 (0.004), p53 (0.022).

19

Figure 4. Human Apoptosis Antibody Array X-ray film with respective ImageJ software protein
profiling analysis using color intensities to reveal spot signal densities of various apoptotic
protein concentration for Breast Cancer cell lines (A) MDA-MB 157, (B) 93A and (C) 93B after
treatment with 2mg SB. Some significant apoptotic proteins observed were: Bad, Bax, Bid, Bim,
C3, C8, cytoC, DR6, HTRA, IGFBP-5, p27, p53, TNF-B, TRAILR-1, and TRAILR-2.

Table 2. One-way ANOVA for Pro-apoptotic proteins in Breast Cancer Cell Line MDA-MB 157

20

Table 3. One-way ANOVA for Pro-apoptotic proteins in Breast Cancer Cell Line 93A
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Table 4. One-way ANOVA for Pro-apoptotic proteins in Breast Cancer Cell Line 93B
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Based on the quantitative values obtained from the ImageJ software protein profiling
analysis revealing spot signal densities of various apoptotic protein concentration, the following
histogram were produced, where a visual comparison between positive, negative and treatment
group was performed for each cell line (Figure 5).
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Figure 5. Expression of Pro-apoptotic and Anti-apoptotic Proteins in APC-Mutant Breast Cancer
Cell lines (A) MDA-MB-157, (B) 93A, (C) 93B from spot signal densities obtained through
ImageJ software (NIH) data from Figure 4. Green box highlights significant pro-apoptotic
proteins that exhibited statistically significant difference after statistical analysis.
Discussion
Fluorescence results revealed that aqueous extract of S. barbata induced a statistically
significant percentage of apoptosis in the three breast cancer cell lines when the negative and
treatment groups were compared after both 1-hour and 3-hour incubation periods. Taking said
results into consideration, we can conclude that S. barbata modulates apoptotic mechanism when
added as a treatment.
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Human Apoptosis Antibody Array protein profiling results demonstrated that there was a
statistically significant difference between groups in the expression of pro-apoptotic proteins.
Both BIM, and IGFBP-4 were significantly modulated in all breast cancer cell lines. BIM is a
peptide found to induce cytochrome c release from mitochondria in vitro triggering apoptosis by
binding and inactivating the antiapoptotic BCL2 relatives. (Tzifi et al., 2012). Similarly, IGFBP4 is an IGF binding proteins well known for its growth inhibitory effect (Durai et al., 2007). Both
proteins very important in the cellular apoptotic pathways. Cell line 93A expressed the highest
protein signal intensity for pro-apoptotic proteins with treatment in comparison to MDA-MB 157
and 93B, leading us to conclude that S. barbata had a greater effect on cell line 93A. Taking into
consideration that 93A is an APC mutant, genetically modified to be more resistant to treatment
(VanKlompenberg, M. K., et al, 2004), results show high hope for treatment effectiveness in
normal breast cancer cell. Even though 93B results showed that almost all proteins had p<0.05,
values are not relievable. This is due to the fact that during experimentation a handling error was
performed, causing a fold to form in the membrane and producing a band, which caused for
values to be skewed; this can be seen both in the one-way ANOVA (Table 4) as well as the
histogram for cell line 93B (Figure 7); where negative control group had the greatest protein
expression even though only water was added.
Even though both pro-apoptotic and anti-apoptotic proteins were tested through the
experimental procedure, in this study only the analysis of the pro-apoptotic proteins among the
three cell lines was performed. Future experimentation by the Phytochemical and
Chemoprevention Research Lab in the Biology department will focus on analyzing how the antiapoptotic proteins were modulated by S. barbata.
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Overall, results suggest that S. barbata contains phytochemicals that induce apoptosis in
breast cancer cell lines MDA-MB-157, 93A, and 93B by modulating pro-apoptotic proteins; the
most significant being Bad, Bax, Bid, Bim, C3, IGFBP-4, p27 and p53.
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